mRNA-based therapeutics: looking beyond COVID-19 vaccines

H Parhiz, EN Atochina-Vasserman, D Weissman - The Lancet, 2024 - thelancet.com
Recent advances in mRNA technology and its delivery have enabled mRNA-based
therapeutics to enter a new era in medicine. The rapid, potent, and transient nature of mRNA …

Prevention, treatment and cure of HIV infection

RJ Landovitz, H Scott, SG Deeks - Nature Reviews Microbiology, 2023 - nature.com
The development of antiretroviral therapy for the prevention and treatment of HIV infection
has been marked by a series of remarkable successes. However, the efforts to develop a …

Immunological memory diversity in the human upper airway

SI Ramirez, F Faraji, LB Hills, PG Lopez, B Goodwin… - Nature, 2024 - nature.com
The upper airway is an important site of infection, but immune memory in the human upper
airway is poorly understood, with implications for COVID-19 and many other human …

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

T Schiffner, I Phung, R Ray, A Irimia, M Tian… - Nature …, 2024 - nature.com
A key barrier to the development of vaccines that induce broadly neutralizing antibodies
(bnAbs) against human immunodeficiency virus (HIV) and other viruses of high antigenic …

Recent progress in mRNA cancer vaccines

R Yao, C **e, X **a - Human Vaccines & Immunotherapeutics, 2024 - Taylor & Francis
The research and development of messenger RNA (mRNA) cancer vaccines have gradually
overcome numerous challenges through the application of personalized cancer antigens …

Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site

TG Caniels, M Medina-Ramìrez, S Zhang… - Science …, 2024 - science.org
Eliciting potent and broadly neutralizing antibodies (bnAbs) is a major goal in HIV-1 vaccine
development. Here, we describe how germline-targeting immunogen BG505 SOSIP …

mRNA vaccines: The future of prevention of viral infections?

P Rzymski, A Szuster‐Ciesielska… - Journal of medical …, 2023 - Wiley Online Library
Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

KW Cohen, SC De Rosa, WJ Fulp… - Science translational …, 2023 - science.org
The engineered outer domain germline targeting version 8 (eOD-GT8) 60-mer nanoparticle
was designed to prime VRC01-class HIV-specific B cells that would need to be matured …

Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates

JM Steichen, I Phung, E Salcedo, G Ozorowski… - Science, 2024 - science.org
Germline-targeting immunogens hold promise for initiating the induction of broadly
neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen …